Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes (original) (raw)

• Grunstein, M. Histone acetylation in chromatin structure and transcription. Nature 389, 349–352 (1997).
  Article CAS Google Scholar
• Laherty, C.D. et al. Histone deacetylases associated with the mSin3 corepressor mediate Mad transcriptional repression. Cell 89, 349–356 (1997).
  Article CAS Google Scholar
• Nagy, L. et al. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A and histone deacetylase. Cell 89, 373–380 (1997).
  Article CAS Google Scholar
• Kosugi, H. et al. Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy. Leukemia 13, 1316–1324 (1999).
  Article CAS Google Scholar
• Kouzarides, T. Histone acetylases and deacetylases in cell proliferation. Curr. Opin. Genet. Dev. 9, 40–48 (1999).
  Article CAS Google Scholar
• Guillemin, K. & Krasnow, M.A. The hypoxic response: huffing and HIFing. Cell 89, 9–12 (1997).
  Article CAS Google Scholar
• Ryan, H.E., Lo, J. & Johnson, R.S. HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO J. 17, 3005–3015 (1998).
  Article CAS Google Scholar
• Kim, K.W. et al. Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma. Cancer Res. 58, 348–351 (1998).
  CAS Google Scholar
• Carmeliet, P. et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394, 485–490 (1998).
  Article CAS Google Scholar
• Nor, J.E., Christensen, J., Mooney, D.J. & Polverini, P.J. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am. J. Pathol. 154, 375–384 (1999).
  Article CAS Google Scholar
• Gupta, K. et al. VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Exp. Cell Res. 247, 495–504 (1999).
  Article CAS Google Scholar
• Baek, J.H. et al. Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis. Oncogene 19, 4621–4631 (2000).
  Article CAS Google Scholar
• Gerber, H.P., Condorelli, F., Park, J. & Ferrara, N. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is upregulated by hypoxia. J. Biol. Chem. 272, 23659–23667 (1997).
  Article CAS Google Scholar
• Waltenberger, J., Mayr, U., Pentz, S. & Hombach, V. Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia. Circulation 94, 1647–1654 (1996).
  Article CAS Google Scholar
• Kwon, H.J., Owa, T., Hassig, C.A., Shimada, J. & Schreiber, S.L. Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase. Proc. Natl. Acad. Sci. USA 95, 3356–3361 (1998).
  Article CAS Google Scholar
• Ravi, R. et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α. Genes Dev. 14, 34–44 (2000).
  CAS PubMed Central Google Scholar
• Stratmann, R., Krieg, M., Haas, R. & Plate, K.H. Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene. J. Neuropathol. Exp. Neurol. 56, 1242–1252 (1997).
  Article CAS Google Scholar
• Pal, S., Claffey, K.P., Dvorak, H.F. & Mukhopadhyay, D. The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways. J. Biol. Chem. 272, 27509–27512 (1997).
  Article CAS Google Scholar
• Royds, J.A., Dower, S.K., Qwarnstrom, E.E. & Lewis, C.E. Response of tumour cells to hypoxia: role of p53 and NF-κB. Mol. Pathol. 51, 55–61 (1998).
  Article CAS Google Scholar
• Gnarra, J.R. et al. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc. Natl. Acad. Sci. USA 93, 10589–10594 (1996).
  Article CAS Google Scholar
• Schmaltz, C., Hardenbergh, P.H., Wells, A. & Fisher, D.E. Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol. Cell. Biol. 18, 2845–2854 (1998).
  Article CAS Google Scholar
• Long, X. et al. p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes. J. Clin. Invest. 99, 2635–2643 (1997).
  Article CAS Google Scholar
• Blagosklonny, M.V. et al. p53 inhibits hypoxia-inducible factor-stimulated transcription. J. Biol. Chem. 273, 11995–11998 (1998).
  Article CAS Google Scholar
• Krieg, M. et al. Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hoppel-Lindau tumor suppressor gene loss of function. Oncogene 19, 5435–5443 (2000).
  Article CAS Google Scholar
• Mukhopadhyay, D., Tsiokas, L. & Sukhatme, V.P. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res. 55, 6161–6165 (1995).
  CAS Google Scholar
• Mukhopadhyay, D., Knebelmann, B., Cohen, H.T., Ananth, S. & Sukhatme, V.P. The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity. Mol. Cell. Biol. 17, 5629–5639 (1997).
  Article CAS Google Scholar
• Krieg, M., Marti, H.H. & Plate, K.H. Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function. Blood 92, 3388–3393 (1998).
  CAS Google Scholar
• Zhong, H. et al. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res. 59, 5830–5835 (1999).
  CAS Google Scholar
• Varia, M.A. et al. Pimonidazole: A novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma. Gynecol. Oncol. 71, 270–277 (1998).
  Article CAS Google Scholar
• Meininger, C.J., Schelling, M.E. & Granger, H.J. Adenosine and hypoxia stimulate proliferation and migration of endothelial cells. Am. J. Physiol. 255, H554–H562 (1988).
  CAS Google Scholar
• Conrad, K.P. & Benyo, D.F. Placental cytokines and the pathogenesis of preeclampsia. Am. J. Reprod. Immunol. 37, 240–249 (1997).
  Article CAS Google Scholar
• Hassig, C.A. et al. A role for histone deacetylase activity in _HDAC1_-mediated transcriptional repression. Proc. Natl. Acad. Sci. USA 95, 3519–3524 (1998).
  Article CAS Google Scholar
• Dangond, F. & Gullans, S.R. Differential expression of human histone deacetylase mRNAs in response to immune cell apoptosis induction by trichostatin A and butyrate. Biochem. Biophys. Res. Commun. 247, 833–837 (1998).
  Article CAS Google Scholar
• Bartl, S. et al. Identification of mouse histone deacetylase 1 as a growth factor-inducible gene. Mol. Cell. Biol. 17, 5033–5043 (1997).
  Article CAS Google Scholar
• Nan, X. et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393, 386–389 (1998).
  Article CAS Google Scholar
• Schroeder, M. & Mass, M.J. CpG methylation inactivates the transcriptional activity of the promoter of the human p53 tumor suppressor gene. Biochem. Biophys. Res. Commun. 235, 403–406 (1997).
  Article CAS Google Scholar
• Prowse, A.H. et al. Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors. Am. J. Hum. Genet. 60, 765–771 (1997).
  CAS PubMed Central Google Scholar
• Herman, J.G. et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA 91, 9700–9704 (1994).
  Article CAS Google Scholar
• Cameron, E.E., Bachman, K.E., Myohanen, S., Herman, J.G. & Baylin, S.B. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nature Genet. 21,103–107 (1999).
  Article CAS Google Scholar
• Selker, E.U. Trichostatin A causes selective loss of DNA methylation in Neurospora. Proc. Natl. Acad. Sci. USA 95, 9430–9435 (1998).
  Article CAS Google Scholar
• Morwenna, S. & Ratcliffe, W.P. Mammalian oxygen sensing and hypoxia inducible factor-1. Int. J. Biochem. Cell Biol. 29, 1419–1432 (1997).
  Article CAS Google Scholar
• Kim, M.S. et al. Anti-angiogenic and Anti-invasive Activity of Torilin, a Sesquiterpene isolated from Torilis japonica. Int. J. Cancer 87, 269–275 (2000).
  Article CAS Google Scholar
• Yamamoto, H., Itoh, F., Hinoda, Y. & Imai, K. Inverse association of cell adhesion regulator messenger RNA expression with metastasis in human colorectal cancer. Cancer Res. 56, 3605–3609 (1996).
  CAS Google Scholar
• Passaniti, A. et al. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest. 67, 519–528 (1992).
  CAS Google Scholar
• Lee, Y.M. et al. Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: A possible signal for vessel development. Dev. Dyn. 220, 175–186 (2001).
  Article CAS Google Scholar